Visx attempts to deter raider with "poison pill" plan
This article was originally published in Clinica
Executive Summary
Visx has set in place a takeover defence "poison pill" plan after financier Carl Icahn announced plans to buy a $15 million stake in the eye laser company, amounting to around 11% of outstanding shares.